0000-0002-1038-7216 About
Niladri Haldar is a Ph.D. candidate in the Nanobioscience Group at the Agharkar Research Institute, Pune, India, under the supervision of Dr. Virendra Gajbhiye. His doctoral research focuses on engineering next-generation targeted nanomedicine platforms for cancer therapy, with a strong emphasis on nucleic acid delivery and reprogramming the tumor microenvironment to enhance therapeutic response. His work centers on developing lipid-based nanocarriers to enhance intracellular delivery of CRISPR-Cas9 systems to triple-negative breast cancer (TNBC) cells, alongside biodegradable silica nanoparticle platforms for siRNA-mediated oncogene silencing, aiming to overcome key biological and translational barriers in gene modulation therapies.
He has actively disseminated his work at national and international scientific forums and received the Best Poster Award at the Indian Association for Cancer Research Annual Meeting (2025) and the Indian Association of Biomedical Scientists Annual Conference (2025). In 2026, he was selected as a member of the Controlled Release Society Young Scientists Committee (CRS YSC), where he contributes to initiatives that support early-career researchers and foster global collaboration in drug delivery and nanomedicine.
Employment
Employment history is unavailable.
Education
-
Agharkar Research Institute Ph.D2021 - Present
Projects & Funding
Projects & funding information is unavailable.
Publications (16)
- Multitalented Hybrid Targeted Nanoconstructs Selectively Repress Survival Genes and Induce Breast Tumor Regression In Vivo Save
- Triphenylphosphonium-functionalised cubosomes for mitochondrial-targeted delivery of 5-fluorouracil and lycopene in skin cancer therapy Save
- Biological ligands and applications in drug delivery Save
- Biologically synthesized metallic nanocarriers for efficient therapy of breast cancer Save
- Cell membrane-camouflaged nanocarriers: A cutting-edge biomimetic technology to develop cancer immunotherapy Save
- Exploring intranasal drug delivery via nanocarriers: A promising glioblastoma therapy Save
- Gold Nanorods (GNRs): A Golden Nano Compass to Navigate Breast Cancer by Multimodal Imaging Approaches Save
- In response to the COVID-19 pandemic: nanomedicine preparedness for mucormycosis and aspergillosis treatment Save
- αvβ3 integrin aptamer functionalized pH-responsive lipid polymer hybrid nanoparticles for targeted co-delivery of paclitaxel and tamoxifen Save
- Molecular authentication, metabolite profiling and in silico–in vitro cytotoxicity screening of endophytic Penicillium ramusculum from Withania somnifera for breast cancer therapeutics Save